Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Duggal
Harpreet S
HS
Singh
Ira
I
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D010054:Brief Psychiatric Rating Scale; D002230:Carbidopa / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D013844:Thiazoles / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D004338:Drug Combinations; D010879:Piperazines; D013844:Thiazoles; D007980:Levodopa; C092292:ziprasidone; D002230:Carbidopa